ClinicalTrials.Veeva

Menu

Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Functions

Ewha Womans University logo

Ewha Womans University

Status

Completed

Conditions

Healthy Adults With Subjective Memory Complaints

Treatments

Dietary Supplement: TF 600mg
Dietary Supplement: TF 1200mg
Dietary Supplement: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT02377024
EBI_CT_TF

Details and patient eligibility

About

The objective of this study is to demonstrate the cognitive enhancement effect and safety of Tremella Fuciformis, using the cognitive and clinical indicators (e.g. memory, attention, and psychomotor speed) and the latest brain imaging methods for healthy adults suffering subjective cognitive impairment.

Enrollment

75 patients

Sex

All

Ages

40 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 40 and 65 years old
  • Global Deterioration Scale score (GDS) of 2
  • High school or higher levels of education.

Exclusion criteria

  • Current pregnancy or breast-feeding
  • Evidence of neurologic or medical conditions
  • Axis I diagnosis when assessed by the board certified psychiatrist using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorder, 4th edition (DSM-IV)(SCID-IV)
  • Mini-mental status examination score of 24 or less
  • Clinical Dementia Rating score of 0.5 or more suggesting cognitive impairment beyond self-perceived subjective deficits
  • Intelligence quotient less than 70
  • Contraindications to magnetic resonance imaging (MRI)
  • Use of psychotropics in last 3 months
  • Use of oral contraceptive medication
  • Participation in other clinical trials during the study period that might affect the outcome of the present study
  • Allergic adverse reactions to mushrooms

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

75 participants in 3 patient groups, including a placebo group

TF 600mg
Experimental group
Description:
TF 600mg/day
Treatment:
Dietary Supplement: TF 600mg
TF 1200mg
Experimental group
Description:
TF 1200mg/day
Treatment:
Dietary Supplement: TF 1200mg
placebo
Placebo Comparator group
Description:
placebo
Treatment:
Dietary Supplement: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems